Evonik Industries AG annual operating cash flow
2021
2022
2023
2024
2025
Evonik Industries AG Operating Cash Flow Growth & History (EVK)
Evonik Industries AG's operating cash flow was €1.44B for fiscal 2025.
View full Evonik Industries AG company overviewEvonik Industries AG annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.44B | −€270.0M | −15.76% |
| 2024 | 2024-12-31 | €1.71B | €119.0M | +7.47% |
| 2023 | 2023-12-31 | €1.59B | −€56.0M | −3.39% |
| 2022 | 2022-12-31 | €1.65B | −€165.0M | −9.09% |
| 2021 | 2021-12-31 | €1.81B | — | — |
Evonik Industries AG quarterly operating cash flow
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €229.0M | €264.0M | — |
| Q1 2026 | 2026-03-31 | €407.0M | €22.0M | +5.71% |
| Q4 2025 | 2025-12-31 | €612.0M | — | — |
| Q2 2025 | 2025-06-30 | −€35.0M | — | — |
| Q1 2025 | 2025-03-31 | €385.0M | — | — |
Evonik Industries AG operating cash flow trends
Between the periods ended 2021-12-31 and 2025-12-31, Evonik Industries AG's operating cash flow decreased from €1.81B to €1.44B, a change of −€372.0M. The latest reported quarter, Q2 2026, shows €229.0M.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company official filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evonik Industries AG source filings ↗Community posts
Evonik declines takeover negotiations after BASF improves its approach
Evonik ($EVK)’s executive board declined to enter takeover negotiations with BASF ($BAS) after reviewing the larger chemicals group’s renewed approach. Reuters reported that the improved proposal values Evonik at €24 a share, or approximate ...
Evonik reportedly rejects BASF’s €10.3 billion takeover approach
Evonik ($EVK) has rejected a BASF ($BAS) takeover proposal worth approximately €10.3 billion, or €22.15 per share, as inadequate, according to Reuters sources. BASF said its approach remained disciplined and that assessing potential synergi ...
